Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans-Joachim Böhm

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Drug Discovery Today|January 16, 2002
Virtual screening and fast automated docking methodsGisbert Schneider, Hans-Joachim Böhm
Drug Discovery Today. Technologies|July 2, 2014
Scaffold hoppingHans-Joachim Böhm, Alexander Flohr, Martin Stahl
Nature Reviews. Drug Discovery|May 17, 2003
Hit and lead generation: beyond high-throughput screeningKonrad H Bleicher, Hans-Joachim Böhm, Klaus Müller, et al.
Chembiochem : a European Journal of Chemical Biology|May 4, 2004
Fluorine in medicinal chemistryHans-Joachim Böhm, David Banner, Stefanie Bendels, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitorsKatrin Groebke Zbinden, Ulrike Obst-Sander, Kurt Hilpert, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Drug Discovery Today|January 16, 2002
Virtual screening and fast automated docking methodsGisbert Schneider, Hans-Joachim Böhm
Drug Discovery Today. Technologies|July 2, 2014
Scaffold hoppingHans-Joachim Böhm, Alexander Flohr, Martin Stahl
Nature Reviews. Drug Discovery|May 17, 2003
Hit and lead generation: beyond high-throughput screeningKonrad H Bleicher, Hans-Joachim Böhm, Klaus Müller, et al.
Chembiochem : a European Journal of Chemical Biology|May 4, 2004
Fluorine in medicinal chemistryHans-Joachim Böhm, David Banner, Stefanie Bendels, et al.
Bioorganic & Medicinal Chemistry Letters|October 11, 2005
Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitorsKatrin Groebke Zbinden, Ulrike Obst-Sander, Kurt Hilpert, et al.
Pageof 1